Work

Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing advanced or recurrent gynecological cancers.

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17512

Authors: Lei Yuan, Yiting Bao

Institutions: Shanghai Medical College of Fudan University, Fudan University, Obstetrics and Gynecology Hospital of Fudan University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410813631

Cites:

Cited by: 1

Related to: 10